Related Experiment Videos
Spread of hepatitis-B infections. A seroepidemiologic study
Summary
Hepatitis B virus (HBV) infections are widespread, with neutralizing antibodies (anti-HBs) more prevalent than the surface antigen (HBs Ag). Subtype analysis revealed distinct HBV profiles in Italy and Tanzania.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Hepatitis B virus (HBV) infection is a significant global health concern.
- Understanding the prevalence and subtypes of HBV is crucial for public health strategies.
- Radioimmunoassay (RIA) offers a method for detecting HBV markers.
Purpose of the Study:
- To assess the prevalence of hepatitis B virus (HBV) infections using radioimmunoassay (RIA).
- To determine the distribution of HBV subtypes (HBs Ag and anti-HBs) in different populations.
- To investigate the presence of anti-HBs in immunoglobulin preparations.
Main Methods:
- Solid-phase radioimmunoassay (RIA) for simultaneous detection and quantitation of HBs Ag and anti-HBs.
- RIA used for validation of positive reactions and determination of serum subtype specificity.
- Analysis of sera from various population groups, including healthy individuals, institutionalized subjects, renal patients, and blood donors.
Main Results:
- Neutralizing anti-HBs were found at a prevalence nearly 4-fold higher than HBs Ag, often at low titers.
- High frequencies of HBs Ag and anti-HBs were observed in Italian and Tanzanian populations, institutionalized subjects, renal patients, and blood donors.
- In Italy, 80.2% of HBV markers were subtype 'ay', while in Tanzania, 72.3% were subtype 'ad', with 'w' as a common secondary determinant.
- Low-titer anti-HBs with 'a' and 'd' specificity were detected in standard immunoglobulins from the USA.
Conclusions:
- HBV infection is prevalent across diverse populations, with neutralizing antibodies being more common than the antigen.
- Significant geographical variations in HBV subtypes exist, with 'ay' dominant in Italy and 'ad' in Tanzania.
- The findings contribute to mapping HBV subtypes in Africa and highlight the presence of anti-HBs in immunoglobulin preparations.